Cargando…
EZH2-regulated immune risk score prognostic model predicts outcome of clear cell renal cell carcinoma
BACKGROUND: The enhancer of zeste homolog 2 (EZH2) plays an important role in the tumor microenvironment (TME), and EZH2 in shaping the epigenetic landscape of CD8(+) T cell fate and function, with a particular emphasis on cancer. Here, high EZH2 expression always leads to less CD8(+) T cell infiltr...
Autores principales: | Xu, Shan, Ma, Bohan, Feng, Xiaoyu, Yao, Chen, Jian, Yanlin, Chen, Yule, Wang, Xinyang, Xie, Hongjun, Li, Lei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9906105/ https://www.ncbi.nlm.nih.gov/pubmed/36760869 http://dx.doi.org/10.21037/tau-22-817 |
Ejemplares similares
-
G Protein γ subunit 7 loss contributes to progression of clear cell renal cell carcinoma
por: Xu, Shan, et al.
Publicado: (2019) -
External Validation of the Prognostic Value of an Immune-Associated Gene Panel for Clear Cell Renal Cell Carcinomas
por: Xie, Zhiwen, et al.
Publicado: (2021) -
Prognostic prediction and immunotherapy response analysis of the fatty acid metabolism-related genes in clear cell renal cell carcinoma
por: Yao, Qinfan, et al.
Publicado: (2023) -
Identification and validation of an immune-related gene prognostic signature for clear cell renal carcinoma
por: Hua, Shan, et al.
Publicado: (2022) -
Prognostic Value of Plasma and Urine Glycosaminoglycan Scores in Clear Cell Renal Cell Carcinoma
por: Gatto, Francesco, et al.
Publicado: (2016)